Alitair Pharmaceuticals
Morristown, US · Delaware corporation
Find your way into Alitair Pharmaceuticals
Sign up to see every warm intro you have to Alitair Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alitair Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 4 of 5 rounds · 2015–2020
▶$35KraisedNov 2020 · 3 investors · PharmaceuticalsRule 506(b)
▶$35KraisedNov 2020 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert CasaleDirector
- James E. HoyesExecutive Officer, Director
- Offering amount
- $31M
- Amount sold
- $35K
- Minimum investment
- $5K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$115KraisedOct 2018 · 3 investors · PharmaceuticalsRule 506(b)
▶$115KraisedOct 2018 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- William W. HowardExecutive Officer, Director
- Frank GuarinoExecutive Officer
- Robert CasaleDirector
- James E. HoyesExecutive Officer, Director
- Offering amount
- $32M
- Amount sold
- $115K
- Minimum investment
- $5K
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MofferedJul 2017 · PharmaceuticalsRule 506(b)
▶$5MofferedJul 2017 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert CasaleDirector
- James E. HoyesExecutive Officer, Director
- William W. HowardExecutive Officer, Director
- Frank GuarinoExecutive Officer
- Offering amount
- $5M
- Minimum investment
- $5K
- Placement agents
- Network 1 Financial Securities, Inc.
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100KraisedMar 2017 · 1 investors · PharmaceuticalsRule 506(b)
▶$100KraisedMar 2017 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- William W HowardExecutive Officer, Director
- Offering amount
- $3.1M
- Amount sold
- $100K
- Minimum investment
- $5K
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$910.8KraisedSep 2015 · 18 investors · Pharmaceuticals
▶$910.8KraisedSep 2015 · 18 investors · Pharmaceuticals
Officers, directors & promoters on the filing
- William W HowardExecutive Officer
- Offering amount
- $937.5K
- Amount sold
- $910.8K
- Minimum investment
- $5K
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 04
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Alitair Pharmaceuticals raised?
- Alitair Pharmaceuticals has disclosed $1.2M raised across 4 of its 5 known rounds.
- Where is Alitair Pharmaceuticals headquartered?
- Alitair Pharmaceuticals is headquartered in Morristown, US.
